Caremark controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2026
Pennsylvania sues insulin makers and PBMs over alleged insulin price collusion
Lawsuit filed
Pennsylvania filed a lawsuit against Eli Lilly and Co., Novo Nordisk Inc., Sanofi-Aventis US LLC, and several pharmacy benefit managers (PBMs), including Caremark, alleging that they colluded to raise insulin prices. The suit seeks structural changes, restitution, and financial penalties. The allegations concern the pricing of insulin and the roles of the manufacturers and PBMs named in the action.
Pennsylvania sued Eli Lilly and Co., Novo Nordisk Inc., Sanofi-Aventis US LLC, and several PBMs, alleging that they colluded to raise insulin prices. The lawsuit seeks structural changes, restitution, and financial penalties.
Source excerpt
The pharmaceutical companies included in the Pennsylvania case are Eli Lilly and Co., Novo Nordisk Inc., and Sanofi-Aventis US LLC. Several PBMs are included as defendants, including Express Scripts, Caremark, and Optum RX.
The state’s lawsuit seeks to institute “structural changes to ensure the companies lower costs to fair market prices and enable options for patients,” restitution for Pennsylvanians harmed by the scheme, and payments including financial penalties paid by the companies and the costs of the state’s investigation and lawsuit.
Last week, Pennsylvania sued a group of pharmaceutical companies and PBMs for allegedly colluding to raise insulin prices unnecessarily.